Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Obstet Gynecol. May 10, 2014; 3(2): 42-44
Published online May 10, 2014. doi: 10.5317/wjog.v3.i2.42
Published online May 10, 2014. doi: 10.5317/wjog.v3.i2.42
Fertility sparing management of endometrial complex hyperplasia and endometrial carcinoma
Alan Farthing, West London Gynaecological Cancer Centre, Imperial NHS Trust, London W10 0HS, United Kingdom
Author contributions: Farthing A solely contributed to this paper.
Correspondence to: Alan Farthing, MD, FRCOG, West London Gynaecological Cancer Centre, Imperial NHS Trust, Du Cane Road, London W10 0HS, United Kingdom. a.farthing@imperial.ac.uk
Received: March 1, 2013
Revised: August 1, 2013
Accepted: August 8, 2013
Published online: May 10, 2014
Processing time: 436 Days and 19.3 Hours
Revised: August 1, 2013
Accepted: August 8, 2013
Published online: May 10, 2014
Processing time: 436 Days and 19.3 Hours
Core Tip
Core tip: Early endometrial cancer is successfully treated with hysterectomy in most cases but an increasing number of women develop the disease whilst still hoping to conceive. We are gathering an increasing amount of data to accurately describe the risk they are taking by undergoing medical treatment with progestagens as an alternative.